MedComm – Future Medicine is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2022. The journal covers Medicine (General): Medical technology and Medicine (General): Computer applications to medicine. Medical informatics.
Authors are required to pay an article processing charge to publish in MedComm – Future Medicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
novel disease mechanisms, multiomics, precision medicine, medical artificial intelligence, regenerative medicine, bioinformatics
At a glance
ISSN
- electronic
- 2769-6456
Frequently asked questions
Is MedComm – Future Medicine peer-reviewed?
Yes — MedComm – Future Medicine operates a Anonymous peer review review process.
Does MedComm – Future Medicine charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does MedComm – Future Medicine publish?
MedComm – Future Medicine publishes research in Medicine (General): Medical technology and Medicine (General): Computer applications to medicine. Medical informatics.
What languages does MedComm – Future Medicine accept?
MedComm – Future Medicine accepts manuscripts in English.
What is the ISSN of MedComm – Future Medicine?
ISSN:
2769-6456 (electronic).How do I submit a manuscript to MedComm – Future Medicine?
Submit through the journal's official portal: visit submission page →